Organization

University of Bath

1 clinical trial

4 abstracts

Abstract
Ability of the reductive x-ray score for psoriatic arthritis (REXSPA) to detect change in an observational cohort of patients with psa
Org: Royal National Hospital for Rheumatic Diseases, Bath, University of Exeter, Cambridge University Hospitals NHS Foundation Trust, University of Bath,
Abstract
A multinational qualitative study in giant cell arteritis: patient perceptions of diagnosis, treatment, impact on health-related quality of life and contextual factors
Org: University of the West of England, Bristol, Bristol University of Oxford, Oxford University Hospitals Bristol NHS Trust, University of Leeds, University of Adelaide,
Abstract
ARE PATIENTS’ AND RHEUMATOLOGISTS’ PERCEPTIONS OF THE BURDEN AND TREATMENT OF PSORIATIC ARTHRITIS ALIGNED? RESULTS FROM THE UPLIFT SURVEY
Org: Brigham and Women’s Hospital, Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute, Hôpital Lariboisière, Paris, France, University of Bath, University of Pennsylvania, Phildelphia, PA,
Abstract
BIMEKIZUMAB MAINTAINED EFFICACY RESPONSES THROUGH 52 WEEKS IN BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG-NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS WHO WERE RESPONDERS AT WEEK 16: RESULTS FROM BE OPTIMAL, A PHASE 3, ACTIVE-REFERENCE STUDY
Org: UCB Pharma, ASST Gaetano Pini-CTO, Dept of Rheumatology, Milan, Italy, University of Milano, European Institute of Oncology, Division of Early Drug Development, Centre for Therapeutic Innovation, University of Bath,